Induction Healthcare - Directorate Changes

Induction Healthcare

07/09/2021 07:00

RNS Number : 8770K

Induction Healthcare Group PLC

07 September 2021

 

Induction Healthcare Group PLC

("Induction", the "Company", or the "Group")

 

Directorate Changes

Senior management team optimises for growth and appointment of Chief Technology Officer

 

Induction (AIM: INHC), a leading virtual care platform driving digital transformation of healthcare systems worldwide, announces important Group board and senior management team changes which the Board believes will ideally position Induction for future growth and success.

 

Dr Hugo Stephenson, Joint CEO, will move to a new role as Group Executive Director, with a focus on group product strategy and business development, particularly in the Asia Pacific region and James Balmain, Joint CEO, will become Induction's sole CEO. Dr Stephenson will also continue to manage the ongoing integration of Induction Attend Anywhere following the acquisition and will play a pivotal role in driving commercial and operational success.

 

The Board is also delighted to welcome Dave Williams as Chief Technology Officer (CTO) with immediate effect. Dave joins from Just Eat plc ("Just Eat"). He has over 25 years' experience leading technology teams, including positions at CompuServe UK Ltd/ AOL UK Ltd and the UK Hydrographic Office, a trading fund of the UK Ministry of Defence. During his tenure as Chief Information Officer at Just Eat, Dave held Group-wide accountability for the stability, scalability and security of all e-commerce platforms and the technology used by Just Eat employees globally.

 

James Balmain commented: "The acquisition of Attend Anywhere has transformed Induction, increasing Group revenue as well as our operational complexity, as our products underpin critical functions within the NHS at scale. These changes will simplify our management structure, increase accountability, and allow us to focus on both delivery for our core UK customers and creation of new opportunities outside the UK - particularly in the Asia-Pacific region where many of our staff are now based.

 

"Dave is a fantastic addition to the Induction senior management team. He has a strong track record with growth businesses and his proven expertise as a technology leader will be invaluable to the Group as we establish our integrated flexible care platform. I look forward to working with him to enhance our portfolio of solutions."

 

Hugo Stephenson commented: "The products we already deliver at scale in the UK have significant potential in new markets. Healthcare systems need tools that allow providers and patients to work together more flexibly, freed from the constraints of having everyone together in the same room at the same time. I am excited about being able to personally focus on these international opportunities while assisting James and the rest of the management team as they continue to deliver operational and commercial success from within our core business."

 

-ENDS-

 

ENQUIRIES

 

Induction
James Balmain, Chief Executive Officer
Dr Hugo Stephenson, Group Executive Director
Via Walbrook PR Ltd: induction@walbrookpr.com
Singer Capital Markets (Nominated Adviser and Broker)
+44 (0) 20 7496 3000
Philip Davies / Kailey Aliyar
Walbrook PR Ltd
induction@walbrookpr.com
Paul McManus / Alice Woodings
Mob: +44(0)7980 541 893 / +44 (0)7407 804 654

 

 

About Induction -  www.inductionhealthcare.com

 

Induction (AIM: INHC) is a leading virtual care platform driving digital transformation of healthcare systems worldwide. Induction solutions enhance the investments hospitals have made and lay the foundation for their future. Our products can enable information sharing between busy doctors, alleviate operational burdens on hospitals or put patients in better control of their care, all while ensuring the highest standards of clinical safety and information security. We unchain staff and patients from the limitations of paper-based and desktop systems, creating substantial time and cost efficiencies.

 

More than 225,000 hospital doctors across multiple territories, including the UK, Ireland, Australia and South Africa, as well as a rapidly growing number of more than 300,000 UK patients, choose Induction solutions.

 

Induction Switch is the number one healthcare collaboration app in the UK, used by the majority of hospital doctors within the NHS. The app helps to increase productivity and enhance communication by securely sharing phone numbers and bleeps, bookmarks, documents and messages in a clinical setting.

 

Induction Guidance provides medical organisations, including most hospital trusts within the NHS, with the ability to collaboratively create, edit, and publish their own local medical guidelines in a secure and locally administrated environment. This increases knowledge of, and adherence to, guidance.

 

Induction Zesty is a market-leading digital platform for patients visiting hospitals. The platform allows patients to book and access their appointments, read their clinical letters, store a copy of their clinical record and provide data to their care teams remotely. It is not just a compelling patient experience, but also delivers significant cost benefits to hospitals.

 

Induction Attend Anywhere is the UK market leader in secondary care video consultations. It helps hospitals, health systems and other customers offer video consultations to patients and service users as a normal part of day-to-day clinical activity. Our vision is for video consultations to improve lives and help address social, access, equity and sustainability challenges by allowing healthcare providers to determine how and when they see a patient based on each individual case: in-person, via video or on the telephone.

 

Induction HealthStream is a proprietary data integration platform that reads and writes patient demographic, appointment and clinical record data between a growing number of hospital EHR systems and the Induction platforms. This connectivity between stakeholders and legacy IT systems adds substantial value to pre-existing health IT investment and allows large-scale adoption of Induction app-based services.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
BOAEADNKELLFEFA